Life Sciences Industry Says FDA Needs Reform
The U.S. Food and Drug Administration suffers from staffing shortages, drawn out reviews, backlogs of applications and a lack of resources, according to a survey of the top pharmaceutical, biotechnology and...To view the full article, register now.
Already a subscriber? Click here to view full article